Copyright â 2014 by John Wiley & Sons
About the Companion Website
Part 1: Electrophysiology
1: Measurement of calcium transient ex vivo
Preparation and fluorescent indicator loading
Analysis and interpretation
2: Confocal imaging of intracellular calcium cycling in isolated cardiac myocytes
Chamber, electrical stimulation, and superfusate delivery apparatus
Confocal microscope system
Cell loading of fluorescent Ca2+ indicators
Weaknesses and strengths of the method and alternative approaches
3: Generating a large animal model of persistent atrial fibrillation
Insights from tachypacing-induced AF models
Generating a tachypacing-induced AF model
Ventricular rate during AF: to ablate or not to ablate
Complications and alternative approaches to study AF
Strengths and weaknesses of the model
4: Confocal imaging of intracellular calcium cycling in the intact heart
Measurement of intracellular Ca2+ transients
Principles and features of confocal microscopy
Limitations, potential pitfalls and alternative approaches
Additional application: use of confocal imaging to determine efficacy of stem cell integration into host myocardium
5: Recording and measurement of action potentials
Choices to make before an experiment
Alternative approaches and extensions
6: Patch-clamp recordings from isolated cardiac myocytes
Theory of patch-clamp recording
Cell-attached configuration
Whole-cell recording configuration
Inside-out excised patch configuration
Outside-out excised patch configuration
Instrumentation for patch-clamp recordings
Experimental aspects of patch-clamp recordings
Whole-cell voltage-clamp protocols, data acquisition, and analysis
Conclusions and future directions
7: Optical mapping of the heart
Tissue preparations (Figure 7.2)
Staining and image acquisition
Data processing and analysis
Weaknesses and strengths of method
Part 2: Isolation and Maintenance of Primary Stem Cells
8: Isolation of colony-forming endothelial progenitor cells
MNC isolation from fresh PB or UCB
EPC-CFA of bulk cell populations in PB, GmPB, BM, or UCB
Optional-1: EPC-CFA of single CD34+ or CD133+ cells in PB, GmPB, BM, or UCB
Optional-2: HELIC assay of single CD34+ or CD133+ cells as cell fate assay of HSC
Competing interests statement
9: Cardiac resident stem cells
Preparation of basic solutions and culture medium
Enzymatic digestion of the mouse heart
Separation of small cells
Sorting c-kit-positive cells using FACS
Weaknesses and strength of the method
Preparation for explant creation
Preparation for cardiosphere formation
Weaknesses and strengths of the method
11: Mesenchymal stem cells
Isolation of human MSCs from BM aspirates
12: Generation and differentiation of human iPS cells
Protocol I: Generation of hiPSC from fibroblasts
Production of the VSV-G Lentivirus (6 days)
Reprogramming of human fibroblasts (∼14 days)
Protocol II: differentiation hiPSCs to myocytes
13: Isolation of neonatal and adult rat cardiomyocytes
Isolation of neonatal rat ventricular cardiomyocytes
Isolation of adult rat cardiomyocytes
Weaknesses and strengths of the method
14: Isolation and culture of vascular smooth muscle cells
Preparation and equipment setup
Strengths and weaknesses of method
15: Isolation and culture of cardiac endothelial cells
Protocol for isolation of mouse cardiac endothelial cells
Materials and preparations
A novel protocol of endothelial cell isolation
16: Isolation and culture of cardiac fibroblasts
Cardiac fibroblasts isolation protocol
Materials and preparations
Procedures for isolation of mouse cardiac fibroblasts
Cell propagation and maintenance
Isolation of cardiac ventricular fibroblasts from rats
17: Murine bone marrow transplantation model
Weaknesses and strengths of the method
18: In vitro differentiation and expansion of vascular endothelial cells derived from mouse embryonic stem cells
Differentiation of ES-cells to Flk-1+ progenitors
ES-cell culture (see Notes 1 and 2)
Purification of Flk-1+ cells
Expansion/differentiation of Flk-1+ cells
Part 3: Manipulation of the Heart and Vessels in Vivo and ex Vivo
Weaknesses and strengths of the method
20: Transverse aortic constriction: a model to study heart failure in small animals
Anesthesia, intubation, and ventilation
Preparation of the operative field
Aortic banding (constriction of transverse aorta)
Confirmation of constriction
Weaknesses and strengths of the method
21: Pharmacological models of hypertrophy and failure
Strengths and weaknesses of the method
Hair removal prior to surgery
23: The Langendorff preparation
Perfusion solution constituents, thermoregulation, and mode of delivery
Recording of left ventricular pressure, ECG, and coronary flow
Weaknesses and strengths of the method
24: Myocarditis and other immunological models of cardiac disease
Strength and weaknesses of the method
25: Models of pacing-induced heart failure
Rapid pacing models
protocols
Functional and hemodynamic expectations
Cellular and biochemical considerations to chronic rapid pacing
Neurohormonal aspects and expectations
Electrophysiology and arrhythmogenesis in chronic rapid pacing
Matrix remodeling and chronic rapid pacing
Chronic pacing model for therapeutic research and development: technical considerations and limitations
Chronic rapid pacing-induced heart failure: the issue of reversibility
26: Porcine myocardial ischemia models
Anesthetized pig model with an angioplasty balloon-induced occlusion
Conscious pig model with an extravascular balloon-induced occlusion
In vivo Matrigel plug assay
Matrigel harvest and analysis
Matrigel mixtures and injections
Preparation of reagents and animals
Reagents for quantification of angiogenesis
Mouse corneal micropocket angiogenesis assay
Preparation of reagents and animals
Monitoring and quantification of angiogenesis
Preparation of controlled slow-release pellet
Discussion and conclusion
28: Immunohistochemical analysis of cardiac tissue
Direct and indirect immunofluorescence
Protocol 1: labeling of primary antibody
Frozen or paraffin sections
Protocol 2: antigen retrieval by microwaving
Ah, those colorful images
Protocol 3: multicolor labeling of formalin-fixed, paraffin embedded myocardial sections
Protocol 4: ligand-blocking of an antibody
29: A murine model of cardiac arrest by exsanguination
Part 4: Small Animal Imaging
30: Blood pressure, telemetry, and vascular measurements in the rodent model
Measurement of blood pressure
Noninvasive arterial BP monitoring (indirect methods)
Invasive arterial BP monitoring (direct methods)
31: The setting: imaging conscious, sedated, or anesthetized rodents
Preparation of rodent and equipment set-up
General steps for preparing mice for imaging studies
32: Echocardiography: standard techniques (M-mode, two-dimensional imaging, and Doppler)
Animal preparation and positioning
Parasternal long axis (PLAX)
Parasternal short axis (PSAX)
Apical four-chamber (A4C)
Apical five-chamber (A5C)
Left ventricular structure and function
Chamber dimensions and wall thickness
Left ventricular systolic function
Load-independent assessment of myocardial contractility
Left ventricular diastolic function
Right ventricular assessment and pulmonary hypertension
Assessment of embryonic and neonatal mice
Assessment of aortic pathology
33: Echocardiography: advanced techniques (tissue Doppler, speckle tracking, and three-dimensional imaging)
Speckle tracking echocardiography
Three-dimensional imaging
3D reconstruction from 2D imaging
34: In vivo tomographic cardiac imaging: positron emission tomography and magnetic resonance imaging
Weaknesses and strength of the methods
Strengths/ weaknesses of the method
Part 5: Metabolism, Mitochondria, and Cell Death
36: Fractionation of cardiomyocytes and isolation of mitochondria
Isolation of mitochondria from whole hearts
Isolation of mitochondria from cultured cardiomyocytes
Strengths and weaknesses of the method
37: Assessment of glucose and fatty acid metabolism ex vivo
Radioactively labeled energy substrates
Measuring myocardial oxygen consumption (MVO2)
Applications of this approach
Limitations and alternative approaches
38: Quantification and characterization of atherosclerotic lesions in mice
Pathological screening of mice
Atherosclerotic lesion analyses
Platelet activation and atherosclerosis
Macrophages and atherosclerosis
Characterization of lesion composition and nature
Weaknesses and strength of the methods
Lesions in atherosclerotic mice
39: Assessment of cell death in the heart
Caveats for the assessment of cell death in experimental models
Entry of propidium iodide into the cell
Release of intracellular proteins
Loss of inner mitochondrial membrane potential (ΔΨm)
Assessing necrosis in vivo
40: Assessment of mitochondrial function in isolated cells
Mitochondrial membrane potential
Mitochondrial mass and biogenesis
Additional measures of mitochondrial function
Weaknesses and strengths of the method
41: Multinuclear NMR spectroscopy of myocardial energetics and substrate utilization in isolated perfused mouse hearts
Creation of fatty acid stock with 13C stable isotopes
Langendorff heart perfusions combined with 31P NMR spectroscopy
Heart tissue processing and 13C NMR spectroscopy of tissue extracts
Variations of the protocol
Strengths and weaknesses of method
42: Measurement of reactive oxygen species in cardiovascular disease
Measurement of the superoxide radical (O2)
Electro paramagnetic resonance spectroscopy (EPR)
Measurement of superoxide radical in mitochondria
Hydrogen peroxide (H2O2) assays
2′7′-dichlorofluorescein diacetate (DCFH-DA)
Measurement of hydrogen peroxide in mitochondria
Thiol-disulfide interchange
Measurement of mitochondrial ROS in living cells
Biological significance of autophagy in the heart
44: Assessment of cardiomyocyte size
Collagenase isolation of myocytes
Weaknesses and strength of the method
Part 6: Manipulation of Gene Expression in Vitro and in Vivo
45: Generation of Cre-loxP mouse models for conditional knockout and overexpression of genes in various heart cells
Conditional knockout (cKO) gene targeting
Conditional knockin (cKI) gene targeting
46: Modulation of myocardial genes via use of adenoviral vectors and RNA interference approaches
Considerations for RNAi transfer
Guidelines for siRNA design
Guidelines of shRNA design
Construction of plasmid vector-based siRNA
Determination of siRNA knockdown effects on gene expression in cells
Construction of adenoviral vector-based siRNA
Transfer of adenoviral vector-based shRNA into the heart
Weaknesses and strengths of the method
47: Overexpression and downregulation of proteins in vitro
Weaknesses and strengths of the method
48: In vivo microRNA studies
Protocol I: Northern blot analysis of miRNAs
Protocol II: Real-time detection of miRNA levels
Protocol III: Preparation of antimiRs for in vivo administration
Weaknesses and strengths of the methods
49: Vascular and cardiac studies in zebrafish
Morpholino (MO) or mRNA microinjection of zebrafish embryos
Whole mount immunofluorescence of zebrafish embryos
Zebrafish live embryo cell tracking
50: Vascular and cardiac studies in Drosophila
Measurement of in vivo cardiac chamber dimension by optical coherence tomography (OCT)
Characterization of heart wall thickness by histology
|